UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014)

CPT: pharmacometrics and systems pharmacology, 2017-07, Vol.6 (7), p.418-429

2017

Volltextzugriff (PDF)

Differential Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate in Subjects With the Metabolic Syndrome

Diabetes (New York, N.Y.), 2003-03, Vol.52 (3), p.803-811

2003

Volltextzugriff (PDF)

OP18 Efficacy and safety of filgotinib for the treatment of perianal fistulizing Crohn’s Disease: Results from the phase 2 DIVERGENCE 2 study

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i019-i021

2022

Volltextzugriff (PDF)

High-Density Lipoprotein (HDL) Transport in the Metabolic Syndrome: Application of a New Model for HDL Particle Kinetics

The journal of clinical endocrinology and metabolism, 2006-03, Vol.91 (3), p.973-979

2006

Volltextzugriff (PDF)

Anomalies in orbifold field theories

Physics letters. B, 2002-01, Vol.525 (1-2), p.169-174

2002

Volltextzugriff (PDF)

The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial disease

European review for medical and pharmacological sciences, 2016-09, Vol.20 (17), p.3618

2016

Volltextzugriff (PDF)

Anomalous couplings for D-branes and O-planes

Nuclear physics. B, 1999-07, Vol.552 (1), p.291-315

1999

Volltextzugriff (PDF)

AB0023 Gene-gene interaction and early rheumatoid arthritis: effects on the response to therapy

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.638-638

2013

Volltextzugriff (PDF)

Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial

Blood, 2016-12, Vol.128 (22), p.4271-4271

2016

Volltextzugriff (PDF)

Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia

Blood, 2016-12, Vol.128 (22), p.479-479

2016

Volltextzugriff (PDF)

Commentary on the MID3 Good Practices Paper

CPT: pharmacometrics and systems pharmacology, 2017-07, Vol.6 (7), p.416-417

2017

Volltextzugriff (PDF)

S94 Tumour Necrosis Factor receptor 1 inhibition using a novel inhaled human antibody reduces inflammation in a human model of lung injury induced by inhaled lipopolysaccharide; a randomised placebo-controlled clinical trial

Thorax, 2013-12, Vol.68 (Suppl 3), p.A50

2013

Volltextzugriff (PDF)

S94 Tumour Necrosis Factor receptor 1 inhibition using a novel inhaled human antibody reduces inflammation in a human model of lung injury induced by inhaled lipopolysaccharide; a randomised placebo-controlled clinical trial: Abstract S94 Table 1

Thorax, 2013-12, Vol.68 (Suppl 3), p.A50-A51

2013

Volltextzugriff (PDF)

Balkan Endemic Nephropathy Risk Associates to the hs1.2 Ig Enhancer Polymorphism

European journal of inflammation, 2012-09, Vol.10 (3), p.393-403

2012

Volltextzugriff (PDF)

A47 CRITICAL ILLNESS: NOVEL MOLECULES AND MODELS: A Novel Tnfr1-Targeting Domain Antibody Attenuates Pulmonary Inflammation In A Human Model Of Lung Injury, Via Actions On The Lung Micro-Vascular Endothelium

American journal of respiratory and critical care medicine, 2014-01, Vol.189, p.1

2014

Volltextzugriff (PDF)

Scale-independent spin effects in D-brane dynamics

Nuclear physics. B, 1998-11, Vol.534 (1), p.223-249

1998

Volltextzugriff (PDF)

Higher derivative F-terms in N = 2 strings

Nuclear physics. B, 1996, Vol.481 (1), p.389-402

1996

Volltextzugriff (PDF)

A note on supersymmetric D-brane dynamics

Physics letters. B, 1998-01, Vol.417 (3), p.233-239

1998

Volltextzugriff (PDF)

Tamoxifen and exemestane (E) in combination as neoadjuvant treatment of hormone sensitive post-menopausal breast cancer women: Clinical efficacy and effects on tumor pathology and immunopathology

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9666-9666

2004

Volltextzugriff (PDF)

Tamoxifen and exemestane (E) in combination as neoadjuvant treatment of hormone sensitive post-menopausal breast cancer women: Clinical efficacy and effects on tumor pathology and immunopathology

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9666-9666

2004

Volltextzugriff (PDF)

BPS states and supersymmetric index in N = 2 type I string vacua

Nuclear physics. B, 1997-09, Vol.501 (2), p.427-444

1997

Volltextzugriff (PDF)

A lattice study of the exclusive B → Kγ decay amplitude, using the Clover action at β = 6.0

Physics letters. B, 1996-01, Vol.365 (1-4), p.275-284

1996

Volltextzugriff (PDF)

A lattice study of the exclusive [formula omitted] decay amplitude, using the Clover action at β = 6.0

Physics letters. B, 1996, Vol.365 (1), p.275-284

1996

Volltextzugriff (PDF)

3P-0768 Differential effects of fenofibrate and atorvastatin on HDL apoAII transport in the metabolic syndrome

Atherosclerosis. Supplements, 2003, Vol.4 (2), p.230-230

2003

Volltextzugriff (PDF)

W09.204 Fenofibrate increases HDL LPAI-AII production in men with the metabolic syndrome

Atherosclerosis. Supplements, 2004-04, Vol.5 (1), p.47-48

2004

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(27)
Buchkapitel
(1)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Science & Technology
(11)
Life Sciences & Biomedicine
(6)
Physical Sciences
(5)
Physics
(5)
Physics, Particles & Fields
(5)
D-Branes
(4)
Humans
(4)
Particle Physics
(4)
Male
(3)
Pharmacology & Pharmacy
(3)
Adult
(2)
Apolipoprotein A-I - Blood
(2)
Astronomy & Astrophysics
(2)
Biological And Medical Sciences
(2)
Boundary States
(2)
Drug Discovery
(2)
Endocrinology & Metabolism
(2)
F-Terms
(2)
Fundamental And Applied Biological Sciences. Psychology
(2)
Kinetics
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014)

Differential Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate in Subjects With the Metabolic Syndrome

OP18 Efficacy and safety of filgotinib for the treatment of perianal fistulizing Crohn’s Disease: Results from the phase 2 DIVERGENCE 2 study

High-Density Lipoprotein (HDL) Transport in the Metabolic Syndrome: Application of a New Model for HDL Particle Kinetics

Anomalies in orbifold field theories

The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial disease

Anomalous couplings for D-branes and O-planes

AB0023 Gene-gene interaction and early rheumatoid arthritis: effects on the response to therapy

Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial

Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia

Commentary on the MID3 Good Practices Paper

S94 Tumour Necrosis Factor receptor 1 inhibition using a novel inhaled human antibody reduces inflammation in a human model of lung injury induced by inhaled lipopolysaccharide; a randomised placebo-controlled clinical trial

S94 Tumour Necrosis Factor receptor 1 inhibition using a novel inhaled human antibody reduces inflammation in a human model of lung injury induced by inhaled lipopolysaccharide; a randomised placebo-controlled clinical trial: Abstract S94 Table 1

Balkan Endemic Nephropathy Risk Associates to the hs1.2 Ig Enhancer Polymorphism

A47 CRITICAL ILLNESS: NOVEL MOLECULES AND MODELS: A Novel Tnfr1-Targeting Domain Antibody Attenuates Pulmonary Inflammation In A Human Model Of Lung Injury, Via Actions On The Lung Micro-Vascular Endothelium

Scale-independent spin effects in D-brane dynamics

Higher derivative F-terms in N = 2 strings

A note on supersymmetric D-brane dynamics

Tamoxifen and exemestane (E) in combination as neoadjuvant treatment of hormone sensitive post-menopausal breast cancer women: Clinical efficacy and effects on tumor pathology and immunopathology

Tamoxifen and exemestane (E) in combination as neoadjuvant treatment of hormone sensitive post-menopausal breast cancer women: Clinical efficacy and effects on tumor pathology and immunopathology

BPS states and supersymmetric index in N = 2 type I string vacua

A lattice study of the exclusive B → Kγ decay amplitude, using the Clover action at β = 6.0

A lattice study of the exclusive [formula omitted] decay amplitude, using the Clover action at β = 6.0

3P-0768 Differential effects of fenofibrate and atorvastatin on HDL apoAII transport in the metabolic syndrome

W09.204 Fenofibrate increases HDL LPAI-AII production in men with the metabolic syndrome

Suchergebnisse filtern